关注
Vikram Kasaragod
Vikram Kasaragod
MRC Laboratory of Molecular Biology
在 mrc-lmb.cam.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Molecular basis of the alternative recruitment of GABAA versus glycine receptors through gephyrin
HM Maric, VB Kasaragod, TJ Hausrat, M Kneussel, V Tretter, ...
Nature communications 5 (1), 5767, 2014
662014
Structure–Function Relationships of Glycine and GABAA Receptors and Their Interplay With the Scaffolding Protein Gephyrin
VB Kasaragod, H Schindelin
Frontiers in molecular neuroscience 11, 317, 2018
542018
Cryo-electron microscopic structure of SecA protein bound to the 70S ribosome
R Singh, C Kraft, R Jaiswal, K Sejwal, VB Kasaragod, J Kuper, J Bürger, ...
Journal of Biological Chemistry 289 (10), 7190-7199, 2014
522014
Mechanisms of inhibition and activation of extrasynaptic αβ GABAA receptors
VB Kasaragod, M Mortensen, SW Hardwick, AA Wahid, V Dorovykh, ...
Nature 602 (7897), 529-533, 2022
432022
Elucidating the molecular basis for inhibitory neurotransmission regulation by artemisinins
VB Kasaragod, TJ Hausrat, N Schaefer, M Kuhn, NR Christensen, ...
Neuron 101 (4), 673-689. e11, 2019
372019
Design and Synthesis of High‐Affinity Dimeric Inhibitors Targeting the Interactions between Gephyrin and Inhibitory Neurotransmitter Receptors
HM Maric, VB Kasaragod, L Haugaard‐Kedström, TJ Hausrat, ...
Angewandte Chemie International Edition 54 (2), 490-494, 2015
282015
Structure of Heteropentameric GABAA Receptors and Receptor-Anchoring Properties of Gephyrin
VB Kasaragod, H Schindelin
Frontiers in molecular neuroscience 12, 191, 2019
262019
Pyridoxal kinase inhibition by artemisinins down-regulates inhibitory neurotransmission
VB Kasaragod, A Pacios-Michelena, N Schaefer, F Zheng, N Bader, ...
Proceedings of the National Academy of Sciences 117 (52), 33235-33245, 2020
252020
Targeting the γ-Aminobutyric Acid Type B (GABAB) Receptor Complex: Development of Inhibitors Targeting the K+ Channel Tetramerization Domain (KCTD) Containing …
V Sereikaite, T Fritzius, VB Kasaragod, N Bader, HM Maric, H Schindelin, ...
Journal of medicinal chemistry 62 (19), 8819-8830, 2019
232019
Modulation of gephyrin-glycine receptor affinity by multivalency
HM Maric, VB Kasaragod, H Schindelin
ACS Chemical Biology 9 (11), 2554-2562, 2014
222014
Structural framework for metal incorporation during molybdenum cofactor biosynthesis
VB Kasaragod, H Schindelin
Structure 24 (5), 782-788, 2016
182016
Novel functional properties of missense mutations in the glycine receptor β subunit in startle disease
I Piro, AL Eckes, VB Kasaragod, C Sommer, RJ Harvey, N Schaefer, ...
Frontiers in Molecular Neuroscience 14, 745275, 2021
92021
The P429L loss of function mutation of the human glycine transporter 2 associated with hyperekplexia
A Kitzenmaier, N Schaefer, VB Kasaragod, T Polster, R Hantschmann, ...
European Journal of Neuroscience 50 (12), 3906-3920, 2019
82019
Artemisinins and their impact on inhibitory neurotransmission
A Pacios-Michelena, VB Kasaragod, H Schindelin
Current Opinion in Pharmacology 59, 19-25, 2021
72021
The molecular basis of drug selectivity for α5 subunit-containing GABAA receptors
VB Kasaragod, T Malinauskas, AA Wahid, J Lengyel, F Knoflach, ...
Nature Structural & Molecular Biology 30 (12), 1936-1946, 2023
42023
Glycine receptor autoantibody binding to the extracellular domain is independent from receptor glycosylation
V Rauschenberger, I Piro, VB Kasaragod, V Hörlin, AL Eckes, CJ Kluck, ...
Frontiers in molecular neuroscience 16, 1089101, 2023
32023
Dual role of dysfunctional Asc-1 transporter in distinct human pathologies, human startle disease, and developmental delay
P Drehmann, S Milanos, N Schaefer, VB Kasaragod, S Herterich, ...
Eneuro 10 (11), 2023
22023
A brain-to-gut signal controls intestinal fat absorption
Q Lyu, W Xue, R Liu, Q Ma, VB Kasaragod, S Sun, Q Li, Y Chen, M Yuan, ...
Nature, 1-8, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–18